A novel method of differential gene expression analysis using multiple cDNA libraries applied to the identification of tumour endothelial genes

Herbert, John M. J.; Stekel, Dov; Sanderson, Sharon; Heath, Victoria L.; Bicknell, Roy
January 2008
BMC Genomics;2008, Vol. 9, Special section p1
Academic Journal
Background: In this study, differential gene expression analysis using complementary DNA (cDNA) libraries has been improved. Firstly by the introduction of an accurate method of assigning Expressed Sequence Tags (ESTs) to genes and secondly, by using a novel likelihood ratio statistical scoring of differential gene expression between two pools of cDNA libraries. These methods were applied to the latest available cell line and bulk tissue cDNA libraries in a two-step screen to predict novel tumour endothelial markers. Initially, endothelial cell lines were in silico subtracted from non-endothelial cell lines to identify endothelial genes. Subsequently, a second bulk tumour versus normal tissue subtraction was employed to predict tumour endothelial markers. Results: From an endothelial cDNA library analysis, 431 genes were significantly up regulated in endothelial cells with a False Discovery Rate adjusted q-value of 0.01 or less and 104 of these were expressed only in endothelial cells. Combining the cDNA library data with the latest Serial Analysis of Gene Expression (SAGE) library data derived a complete list of 459 genes preferentially expressed in endothelium. 27 genes were predicted tumour endothelial markers in multiple tissues based on the second bulk tissue screen. Conclusion: This approach represents a significant advance on earlier work in its ability to accurately assign an EST to a gene, statistically measure differential expression between two pools of cDNA libraries and predict putative tumour endothelial markers before entering the laboratory. These methods are of value and available http://www.compbio.ox.ac.uk/data/diffex.html to researchers that are interested in the analysis of transcriptomic data.


Related Articles

  • Selection and validation of endogenous reference genes using a high throughput approach. Ping Jin; Yingdong Zhao; Ngalame, Yvonne; Panelli, Monica C.; Nagorsen, Dirk; Monsurró, Vladia; Smith, Kina; Nan Hu; Hua Su; Taylor, Phil R.; Marincola, Francesco M.; Ena Wang // BMC Genomics;2004, Vol. 5, p55 

    Background: Endogenous reference genes are commonly used to normalize expression levels of other genes with the assumption that the expression of the former is constant in different tissues and in different physiopathological conditions. Whether this assumption is correct it is, however, still...

  • Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues. Lee, Hakjoo; Maihle, Nita J // Oncogene;6/25/98, Vol. 16 Issue 25, p3243 

    ErbB-3 is a member of the epidermal growth factor receptor (EGFR/ErbB) family. In addition to the previously reported 6.2 kb full-length and 1.4 kb truncated c-erbB3 transcripts, we have observed a 1.7 kb c-erbB3 human transcript in Northern blots that specifically hybridizes to a probe of the...

  • Isolation of growth suppressors from a cDNA expression library. Pestov, Dimitri G; Grzeszkiewicz, Tatiana M; Lau, Lester F // Oncogene;12/17/98, Vol. 17 Issue 24, p3187 

    We describe an experimental procedure for the isolation of growth inhibitory sequences from a complex cDNA library. This approach first takes advantage of the SETGAP technique (selectable expression of transient growth arrest phenotype) to enrich for growth inhibitory sequences, followed by a...

  • Global analysis of differential gene expression between prostate cancer and normal prostate tissues using cDNA microarray of open-reading frame expressed sequence tags (ORESTES). Sarkis, A.S. // Prostate Cancer & Prostatic Diseases;2000 Supplement 1, Vol. 3 Issue 4, pS36 

    Presents an analysis of differential gene expression between prostate cancer and normal prostate tissues using complementary DNA microarray of open-reading frame expressed sequence tags (ORESTES). Results of sequencing of ORESTES fragments; Approximate number of available ORESTES.

  • Identification of candidate molecular markers of nasopharyngeal Carcinoma by tissue microarray and in situ hybridization. Xiong, Shilong; Wang, Qian; Zheng, Lei; Gao, Feng; Li, Junling // Medical Oncology;Dec2011, Vol. 28, p341 

    To scan differentially expressed genes and to identify candidate molecular markers in nasopharyngeal carcinoma (NPC), we analyzed cDNA microarray data by GenMAPP to find specifically expressed genes in NPC and used tissue microarray and in situ hybridization techniques to confirm our microarray...

  • Woodchuck post-transcriptional element induces nuclear export of myotonic dystrophy 3'untranslated region transcripts. Mastroyiannopoulos, Nikolaos P.; Feldman, Mariana L.; Uney, James B.; Mahadevan, Mani S.; Phylactou, Leonidas A. // EMBO Reports;May2005, Vol. 6 Issue 5, p458 

    The woodchuck post-transcriptional regulatory element (WPRE) can naturally accumulate hepatitis transcripts in the cytoplasm, and has been recently exploited as an enhancer of transgene expression. The retention of mutant myotonic dystrophy protein kinase (DMPK) transcripts in the nucleus of...

  • Increased susceptibility to apoptosis in CD45+ myeloma cells accompanied by the increased expression of VDAC1. Liu, S.; Ishikawa, H.; Tsuyama, N.; Li, F. -J.; Abroun, S.; Otsuyama, K. -i.; Zheng, X.; Ma, Z.; Maki, Y.; Iqbal, M. S.; Obata, M; Kawano, M. M. // Oncogene;1/19/2006, Vol. 25 Issue 3, p419 

    Expression of CD45 is quite variable in human myeloma cells and cell lines, such as U266, and CD45+ U266 proliferates in response to a growth factor, interleukin-6. Here, we show that CD45+ myeloma cell lines were more sensitive to various apoptotic stimuli, such as oxidative stress and...

  • Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Konermann, Silvana; Brigham, Mark D.; Trevino, Alexandro E.; Joung, Julia; Abudayyeh, Omar O.; Barcena, Clea; Hsu, Patrick D.; Habib, Naomi; Gootenberg, Jonathan S.; Nishimasu, Hiroshi; Nureki, Osamu; Zhang, Feng // Nature;1/29/2015, Vol. 517 Issue 7536, p583 

    Systematic interrogation of gene function requires the ability to perturb gene expression in a robust and generalizable manner. Here we describe structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. We used these...

  • Clinically relevant cancer biomarkers and pharmacogenetic assays. Patel, Jai N; Mandock, Katherine; McLeod, Howard L // Journal of Oncology Pharmacy Practice;Feb2014, Vol. 20 Issue 1, p65 

    Background: The number of pharmacogenetic assays available is continuously expanding as more molecularly targeted anticancer drugs are under clinical development. While the literature regarding drug–gene associations and therapeutic implications is often robust, reviews regarding clinical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics